World's Best Scientists 2026 revealed!
Mark A. Brockman

Mark A. Brockman

D-Index & Metrics

Immunology

D-Index
57
Citations
10253
World Ranking
3639
National Ranking
95

Research.com Recognitions

  • 1963 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Mark A. Brockman is affiliated with Simon Fraser University in Canada. Their research primarily focuses on medicine, with significant contributions in immunology and microbiology.

The main subfields of study by Mark A. Brockman include infectious diseases, virology, immunology, health, and public health, environmental and occupational health. The principal topics of their work cover a range of issues related to infectious diseases and public health, notably:

  • SARS-CoV-2 and COVID-19 research
  • COVID-19 clinical research studies
  • HIV research and treatment
  • Vaccine coverage and hesitancy
  • HIV/AIDS drug development and treatment
  • HIV/AIDS research and interventions
  • COVID-19 impact on reproduction

Recent papers authored or coauthored by Brockman include the following:

  • "African-led health research and capacity building- is it working?" (2020), published in BMC Public Health
  • "Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults" (2021), published in The Journal of Infectious Diseases
  • "Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy" (2022), published in npj Vaccines
  • "People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses" (2022), published in The Journal of Infectious Diseases
  • "Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose" (2022), published in The Journal of Infectious Diseases

Mark A. Brockman frequently publishes in several venues including bioRxiv (Cold Spring Harbor Laboratory), AIDS, The Journal of Infectious Diseases, Viruses, and Frontiers in Reproductive Health.

Frequent coauthors collaborating with Brockman include:

  • Zabrina L. Brumme
  • Hope R. Lapointe
  • Chanson J. Brumme
  • Francis Mwimanzi
  • Julio Montaner

The scientist has also been recognized as a Fellow of the American Association for the Advancement of Science (AAAS) since 1963.

Best Publications

  • Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction.

    Daniel E Kaufmann;Daniel G Kavanagh;Florencia Pereyra;Florencia Pereyra;John J Zaunders

  • Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication.

    Arne Schneidewind;Mark A. Brockman;Mark A. Brockman;Ruifeng Yang;Rahma I. Adam

  • IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells.

    Mark A. Brockman;Mark A. Brockman;Douglas S. Kwon;Douglas S. Kwon;Douglas S. Kwon;Daniel P. Tighe;David F. Pavlik

  • Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A

    Mark A. Brockman;Arne Schneidewind;Matthew Lahaie;Aaron Schmidt;Aaron Schmidt

  • TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection

    Huabiao Chen;Zaza M Ndhlovu;Zaza M Ndhlovu;Dongfang Liu;Lindsay C Porter

  • HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphocyte Recognition.

    Toshiyuki Miura;Mark A. Brockman;Arne Schneidewind;Michael Lobritz

  • Herpes simplex virus.

    Travis J Taylor;Mark A Brockman;Elizabeth E McNamee;David M Knipe

  • HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins

    Zabrina L. Brumme;Zabrina L. Brumme;Mina John;Jonathan M. Carlson;Chanson J. Brumme

  • Responsiveness of HIV-specific CD4 T cells to PD-1 blockade

    Filippos Porichis;Douglas S. Kwon;Douglas S. Kwon;Douglas S. Kwon;Jennifer Zupkosky;Daniel P. Tighe

  • Structural and Functional Constraints Limit Options for Cytotoxic T-Lymphocyte Escape in the Immunodominant HLA-B27-Restricted Epitope in Human Immunodeficiency Virus Type 1 Capsid

    Arne Schneidewind;Mark A. Brockman;Mark A. Brockman;John Sidney;Yaoyu E. Wang

  • HIV Increases HCV Replication in a TGF-β1–Dependent Manner

    Wenyu Lin;Ethan M. Weinberg;Andrew W. Tai;Lee F. Peng

  • Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults

    Unknown

  • Early Selection in Gag by Protective HLA Alleles Contributes to Reduced HIV-1 Replication Capacity That May Be Largely Compensated for in Chronic Infection

    Mark A. Brockman;Mark A. Brockman;Mark A. Brockman;Zabrina L. Brumme;Zabrina L. Brumme;Zabrina L. Brumme;Chanson J. Brumme;Chanson J. Brumme;Toshiyuki Miura;Toshiyuki Miura

  • Attenuation of multiple Nef functions in HIV-1 elite controllers.

    Philip Mwimanzi;Philip Mwimanzi;Tristan J Markle;Eric Martin;Yoko Ogata

  • HLA-Associated Alterations in Replication Capacity of Chimeric NL4-3 Viruses Carrying gag-protease from Elite Controllers of Human Immunodeficiency Virus Type 1

    Toshiyuki Miura;Mark A. Brockman;Zabrina L. Brumme;Chanson J. Brumme

  • Genetic Characterization of Human Immunodeficiency Virus Type 1 in Elite Controllers: Lack of Gross Genetic Defects or Common Amino Acid Changes

    Toshiyuki Miura;Mark A. Brockman;Chanson J. Brumme;Zabrina L. Brumme

  • Humoral response to herpes simplex virus is complement-dependent

    Xavier J. Da Costa;Mark A. Brockman;Elisabeth Alicot;Minghe Ma

  • HIV-1 Vpu Mediates HLA-C Downregulation.

    Richard Apps;Gregory Q. Del Prete;Pramita Chatterjee;Abigail Lara

  • Impaired Replication Capacity of Acute/Early Viruses in Persons Who Become HIV Controllers

    Toshiyuki Miura;Zabrina L. Brumme;Mark A. Brockman;Pamela Rosato

  • Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy

    Unknown

  • Selective Depletion of High-Avidity Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8+ T Cells after Early HIV-1 Infection

    Mathias Lichterfeld;Xu G. Yu;Stanley K. Mui;Katie L. Williams

  • HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte recognition (Journal of Virology (2009) 83, 6, (2743-2755))

    Toshiyuki Miura;Mark A. Brockman;Arne Schneidewind;Michael Lobritz

Frequent Co-Authors

Zabrina L. Brumme
Zabrina L. Brumme Simon Fraser University
Bruce D. Walker
Bruce D. Walker Harvard University
Thumbi Ndung'u
Thumbi Ndung'u University of KwaZulu-Natal
Chanson J. Brumme
Chanson J. Brumme University of British Columbia
Philip J. R. Goulder
Philip J. R. Goulder University of Oxford
Jonathan M. Carlson
Jonathan M. Carlson Microsoft (United States)
Florencia Pereyra
Florencia Pereyra Harvard University
Todd M. Allen
Todd M. Allen Harvard University
Glenda Gray
Glenda Gray South African Medical Research Council
Alicja Trocha
Alicja Trocha Ragon Institute of MGH, MIT and Harvard

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related online degrees and career pathways can broaden professional opportunities and enhance expertise. Many students consider advancing toward specialized nursing roles, such as psychiatric-mental health nurse practitioners. Programs offering the top online pmhnp programs provide excellent clinical placement rates, ensuring practical experience alongside theoretical knowledge.

Cost is a significant factor for many students. Fortunately, some of the cheapest online pmhnp programs make advanced education more accessible without compromising quality. These affordable options enable aspiring nurse practitioners to develop critical skills for careers in immunology-related healthcare settings.

Understanding potential earnings is also crucial when selecting a career path. According to data on how much do dnps make, Doctor of Nursing Practice graduates can expect competitive salaries that reflect their advanced training and specialization.

For current nurse practitioners aiming to pivot toward acute care, pursuing acute care np certification can be an important step. This certification opens doors to specialized clinical roles, complementing immunology expertise in high-intensity healthcare environments.

Best Scientists Citing Mark A. Brockman

Trending Scientists